XML 17 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 24,365 $ 37,879
General and administrative 20,975 6,568
Total operating expenses 45,340 44,447
Loss from operations (45,340) (44,447)
Interest income, net 5,996 2,239
Other income (expense) 5 (3)
Total other income, net 6,001 2,236
Net loss $ (39,339) $ (42,211)
Net loss per share attributable to common stockholders - basic (in USD per share) $ (0.47) $ (0.79)
Net loss per share attributable to common stockholders - diluted (in USD per share) $ (0.47) $ (0.79)
Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares) 82,834,752 53,163,551
Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares) 82,834,752 53,163,551